Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record now shows recruitment has ended with a note 'No longer looking for participants.' New help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the Intervention/Treatment label formatting was updated.
    Difference
    0.6%
    Check dated 2026-06-13T05:09:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small, non-substantive update to the page.
    Difference
    0.1%
    Check dated 2026-06-05T22:15:45.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend/template update to the page without changing the displayed study information.
    Difference
    0.1%
    Check dated 2026-05-15T14:07:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The study record was updated to add Janssen Scientific Affairs, LLC as a collaborator and remove the National Cancer Institute (NCI); recent timestamps indicate that the record has been refreshed.
    Difference
    0.3%
    Check dated 2026-05-01T09:10:45.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:44:18.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:58:06.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.